
Triana is coordinated by an executive team leveraging on the experience of Advisors gathering some of the country’s leading entrepreneurs, scientific, financial, and industry experts.
Triana Team
| • | Jabril Bensedrine, PhD, Managing Partner |
| • |
Frédéric Champavère, Managing Partner Europe
|
| • |
Jacques-Olivier d'Halluin, Partner
|
| • |
David-Alexandre Baranes, Eng, MS, Partner
|
| • |
Philippe Metais, Business Development France
|
| • |
Lorraine Marchand, Co-Director, Triana Life Sciences
|
| • |
Pamela Yih, Co-Director, Triana Life Sciences
|
| • |
Erik Grimmelmann, PhD, Managing Director, Triana Technologies
|
| • | Bertrand Leseigneur, Project Manager |
Triana Life Sciences Team
| • | Frédéric Champavère, Managing Partner Europe | Founder and Former President Pharma Omnium, Former President Janssen-Cilag (Johnson&Johnson), Former President Eli Lilly France |
| • | Lorraine Marchand, Co-Director | CEO of Ocular Proteomics; Former COO of Clinilabs; Former Executive Director at Bristol Myers Squibb |
| • | Pamela Yih, Co-Director | President Pamela Y-F Yih, Inc; Former Director at Bristol Myers Squibb |
| • | Geert Cauwenbergh, PhD, Advisory Board Member | Chairman of BIO New Jersey | Chairman and CEO of RHEI Pharmaceuticals; Founder, Former Chairman and CEO of Barrier Therapeutics (listed, then sold) |
| • | Tamar Howson, MBA, Advisory Board Member | Advisory Board Member of BIO New Jersey | Member of JSB-Partners; Former SVP Corporate and Business Development at Bristol Myers Squibb; Former SVP and Director of Worldwide Business and Corporate Development at SmithKline Beecham |
| • | Patrick Langlois, PhD, Advisory Board Member | General Partner of PJL Conseils; Former Vice Chairman of the Management Board, Executive Vice President, and Chief Financial Officer of Aventis |
| • | Jerry Sanders, Advisory Board Member | Founder and Managing Director of San Francisco Science; Founder and former CEO of BaFF (sold), ArteriA (sold), X-Cardia (sold), S3 (sold) |
| • | Thierry Teil, MD, MBA, Advisor | Executive Vice President at UCB Pharmaceutical |
| • |
Jerome Chevallier, PharmD, MBA, Advisor | Dermo-Cosmetics Expert |
Triana Technologies Team
| • | Erik Grimmelmann, PhD, Managing Director | Former SVP Technology Infrastructure at Dun&Bradstreet; Former Vice President of Network and Access at AT&T; Board Member of New York Software Industry Association |
| • | Michel Berty, PhD Advisory Board Member | Founder, Former Chairman and CEO of CapGemini USA |
| • | Tommaso Trionfi, MBA, Advisor | Founder and Former CEO of Wimba, Inc. |
| • | Jean-Noel Poirier, MBA, Advisor | Vice President Marketing & Business Development at Global Solar Energy; Former Vice President at First Solar Inc.; Former Global Vice President Marketing at Honeywell |
| • | Ari Ginsberg, PhD, Advisor | Professor at New York University Stern School of Business; Former Director of the Center for Entrepreneurship at NYU Stern |
| • | Kristin Barbato, Advisor | Strategic Planning, conEdison |
| • | Paul Borgese, MBA, Advisor | Manager at Emerging Markets Group of the Associated Press |
| • | John Sweeney, BA, Advisor | Business Development |
| • |
Sudha Bellamkonda, Project Manager |
Support functions
| • | Tornike (Toka) Bolkvadze, In-House Legal Counsel |
| • | Catherine Berthier, Communications |
| • | Bertrand Leseigneur, Project Manager |
Our panel of experts
TRIANA works also with a panel of numerous industry experts who hold leadership positions in the private and public sectors. It includes CEOs and senior executives within the worlds of finance and private equity, directors of public institutions, and managers of international corporations.
Our scalable resources
We mobilize the resources of key partners in United States and Europe. Our network of partners include:
San Francisco Science (San Francisco)
Nextep (Paris)
Home | What We Do | Who We Are | TRIANA at Work | Contact Us |
Login
© Copyright 2008 The TRIANA Group, Inc.